Systemic Hypothermia in Acute Cervical Spinal Cord Injury
3 other identifiers
interventional
120
1 country
7
Brief Summary
This study is a prospective multi-center trial designed to determine the safety profile and efficacy of modest (33ºC) intravascular hypothermia following acute cervical (C1 to C8) Spinal Cord Injury (SCI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2017
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2016
CompletedFirst Posted
Study publicly available on registry
December 13, 2016
CompletedStudy Start
First participant enrolled
August 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
November 21, 2025
November 1, 2025
9 years
December 7, 2016
November 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Neurological improvement on American Spinal Injury Association (ASIA)
Improvement in ASIA Impairment Scale (AIS) after modest hypothermia
Between baseline and 12 months
Neurological improvement on ASIA
Improvement in ASIA motor score after modest hypothermia
Between baseline and 12 months
Secondary Outcomes (2)
Functional improvement in Functional Independence Measure (FIM)
12 months
Functional improvement in Spinal Cord Independence Measure (SCIM)
12 months
Study Arms (2)
Hypothermia
EXPERIMENTALIntravascular hypothermia will be initiated within 24 hours post-injury and 33 degrees Celsius will be maintained for 48 hours.
Control
NO INTERVENTIONStandard of care medical treatment, specific to each individual.
Interventions
To deliver intravascular hypothermia, an Alsius Icy CoolGuard® catheter (US Food and Drug Administration approved, Premarket Notification \[510(k), K030421\]; Alsius Corporation, Irvine, California) will be inserted through the femoral vein using a sterile technique. Patients will be cooled at a maximum rate (2-2.5 ºC/hr.) until they reach the target temperature (T 33 ºC), which will be maintained for 48 hours, and then re-warmed at 0.1 ºC/hr. until normothermia (T 37ºC) is achieved.
Eligibility Criteria
You may qualify if:
- years of age
- AIS Grade A - C
- Glasgow Coma Scale ≥14
- Able to start hypothermia treatment within 24 hours of injury
- Non-penetrating injury. Patients urgently taken to the operating room for surgical reduction may also be included.
You may not qualify if:
- Age \> 70 years
- AIS Grade D
- Hyperthermia on admission (\>38.5ºC)
- Severe systemic injury
- Severe bleeding
- Pregnancy
- Coagulopathy
- Thrombocytopenia
- Known prior severe cardiac history
- Blood dyscrasia
- Pancreatitis
- Reynaud's syndrome
- Cord transection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Miamilead
- United States Department of Defensecollaborator
Study Sites (7)
HonorHealth Research Institute with Barrow Brain and Spine
Phoenix, Arizona, 85027, United States
Jackson Memorial Hospital
Miami, Florida, 33136, United States
Emory University School of Medicine
Atlanta, Georgia, 30303-3049, United States
Indiana University School of Medicine
Indianapolis, Indiana, 46202-1000, United States
University of Maryland School of Medicine
Baltimore, Maryland, 21201, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107-5125, United States
Prisma Health - University of South Carolina
Columbia, South Carolina, 29203, United States
Related Publications (4)
Levi AD, Casella G, Green BA, Dietrich WD, Vanni S, Jagid J, Wang MY. Clinical outcomes using modest intravascular hypothermia after acute cervical spinal cord injury. Neurosurgery. 2010 Apr;66(4):670-7. doi: 10.1227/01.NEU.0000367557.77973.5F.
PMID: 20190669BACKGROUNDDididze M, Green BA, Dietrich WD, Vanni S, Wang MY, Levi AD. Systemic hypothermia in acute cervical spinal cord injury: a case-controlled study. Spinal Cord. 2013 May;51(5):395-400. doi: 10.1038/sc.2012.161. Epub 2012 Dec 18.
PMID: 23247015BACKGROUNDLevi AD, Green BA, Wang MY, Dietrich WD, Brindle T, Vanni S, Casella G, Elhammady G, Jagid J. Clinical application of modest hypothermia after spinal cord injury. J Neurotrauma. 2009 Mar;26(3):407-15. doi: 10.1089/neu.2008.0745.
PMID: 19271964BACKGROUNDVedantam A, Jimsheleishvili G, Harrop JS, Alberga LR, Ahmad FU, Murphy RK, Jackson JB 3rd, Rodgers RB, Levi AD. A prospective multi-center study comparing the complication profile of modest systemic hypothermia versus normothermia for acute cervical spinal cord injury. Spinal Cord. 2022 Jun;60(6):510-515. doi: 10.1038/s41393-021-00747-w. Epub 2022 Jan 10.
PMID: 35013548BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Allan D Levi, MD, PhD
University of Miami
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chairman of Neurological Surgery
Study Record Dates
First Submitted
December 7, 2016
First Posted
December 13, 2016
Study Start
August 4, 2017
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
November 21, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share